AcelRx Pharmaceuticals, Inc. (ACRX)

NASDAQ: ACRX · IEX Real-Time Price · USD
0.735
-0.084 (-10.26%)
At close: Dec 29, 2023, 4:00 PM
0.750
+0.015 (2.04%)
After-hours: Dec 29, 2023, 7:58 PM EST

AcelRx Pharmaceuticals Revenue

AcelRx Pharmaceuticals had revenue of $622.00K in the twelve months ending September 30, 2023, with 31,000.00% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $117.00K. In the year 2022, AcelRx Pharmaceuticals had annual revenue of $1.77M, a decrease of -37.15%.

Revenue (ttm)
$622.00K
Revenue Growth
+31,000.00%
P/S Ratio
20.03
Revenue / Employee
$32,737
Employees
19
Market Cap
12.46M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20221.77M-1.05M
-37.15%
Dec 31, 20212.82M-2.60M
-47.97%
Dec 31, 20205.42M3.13M
136.61%
Dec 31, 20192.29M138.00K
6.42%
Dec 31, 20182.15M-5.84M
-73.10%
Dec 31, 20178.00M-9.36M
-53.94%
Dec 31, 201617.36M-1.91M
-9.89%
Dec 31, 201519.26M14.05M
269.24%
Dec 31, 20145.22M-24.29M
-82.32%
Dec 31, 201329.50M27.11M
1,132.33%
Dec 31, 20122.39M1.32M
123.32%
Dec 31, 20111.07M--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20080--
Dec 31, 20070--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.